Comparative study of three types of mesenchymal stem cell to differentiate into pancreatic β-like cells in vitro.
Experimental and therapeutic medicine
Mo Y, Wang Z, Gao J, Yan Y, Ren H, Zhang F, Qi N, Chen Y.
Publication Overview
Key findings, Countstar context, and access to the original paper.
2021
Stem Cell Research
No items found.
Key Finding
The aim of the present study was to investigate the ability of three types of adult mesenchymal stem cell (MSC) to differentiate into pancreatic β-like cells in vitro in order to identify suitable sources for the treatment of diabetes. The present indicated that MENSCs may be a suitable cell source for the curative treatment of TID.
Countstar Connection
Countstar (model not specified) served as the instrument for cell-count assessment in the study's cell samples during growth assessment in the 2021 Experimental and therapeutic medicine study.
